Tatiane Galindo, executive director of Ortosintese, Brazil’s and Latin America’s leading implant company, provides insights into Ortosintese’s historical commitment to the highest quality standards and her ambitions to further bolstering the development of innovative projects as well as the company’s international footprint, while Ortosintese’s implants are already available in over 30 countries around the world.
Could you please provide our international readers with a brief introduction to Ortosintese and document the company’s current positioning?
"We want to be seen as a global, established, and trustworthy brand that has more than 40 years of experience in Brazil, one of the world’s largest healthcare markets."
